- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-1-1-mer
 - Ligands
 - 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.4: 4 residues within 4Å:- Chain A: S.696, N.697, N.698
 - Chain B: D.784
 
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.789, S.791, Q.792
 
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: A.694, N.1062
 
Ligand excluded by PLIPNAG.7: 3 residues within 4Å:- Chain A: N.1086, T.1088, F.1091
 
Ligand excluded by PLIPNAG.8: 1 residues within 4Å:- Chain A: N.1122
 
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain B: A.694, E.1060, N.1062
 
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain B: F.326, G.327, N.331
 
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain B: N.604, T.606
 
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain B: N.697, G.1119
 - Chain C: D.784
 
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain B: N.789
 
Ligand excluded by PLIPNAG.14: 1 residues within 4Å:- Chain B: N.1122
 
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain B: N.705, N.907, L.910, Q.1059
 
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: Q.883
 - Chain C: A.694, E.1060, N.1062
 
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain B: K.546
 - Chain C: N.268, E.269, N.270
 
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: D.784
 - Chain C: N.697, G.1119
 
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain C: N.1122
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Jones, B.E. et al., LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. Biorxiv (2020)
          


 - Release Date
 - 2021-02-03
 - Peptides
 - Spike glycoprotein: ABC
LY-CoV555 Fab heavy chain: D
LY-CoV555 Fab light chain: E - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-1-1-mer
 - Ligands
 - 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Jones, B.E. et al., LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. Biorxiv (2020)
          


 - Release Date
 - 2021-02-03
 - Peptides
 - Spike glycoprotein: ABC
LY-CoV555 Fab heavy chain: D
LY-CoV555 Fab light chain: E - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E